CTX prevents the body from making a bile acid called CDCA

In individuals with cerebrotendinous xanthomatosis (CTX), a mutation in the CYP27A1 gene prevents an important enzyme (sterol 27-hydroxylase) from working properly. This prevents the body from making chenodeoxycholic acid (CDCA). CDCA plays an important role in regulating the bile acid production process. When there is not enough CDCA, it can cause the buildup of CTX toxins.

Broken CYP27A1 gene prevents the body from making CDCA and causes a buildup of CTX toxins.
 

CTEXLI helps put back 
the CDCA that CTX takes away

CTEXLI is designed to help stop the buildup of CTX toxins. It does this by replacing the CDCA missing in adults with CTX.

CTEXLI replaces CDCA and prevents the buildup of excess CTX toxins.

How does CTEXLI work?

CTEXLI helps to:

Replenish

CDCA, an important bile acid the body has trouble making because of CTX

Restart

the cycle that prevents more harmful toxins from being made

Reduce

levels of harmful toxins in the blood and urine that may lead to CTX signs and symptoms

Talk to a health care provider to learn more about CTEXLI.